Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors—A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia

Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors—A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia

<i>Background</i>: Febrile neutropenia (FN) remains one of the most challenging problems in medical oncology and is a very severe side effect of chemotherapy. Its late consequences, when it is recurrent or of a severe grade, are dose reduction and therapy delays. Current guidelines allow...

Full description

Bibliographic Details
Main Authors: Călin Căinap, Sânziana Cetean-Gheorghe, Laura Ancuta Pop, Daniel Corneliu Leucuta, Doina Piciu, Andra Mester, Cătălin Vlad, Crişan Ovidiu, Alexandra Gherman, Cristina Crişan, Alina Bereanu, Ovidiu Bălăcescu, Anne Marie Constantin, Irina Dicu, Loredana Bălăcescu, Adina Stan, Patriciu Achimaş-Cadariu, Simona Căinap
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Medicina
Subjects:
neutropenia
chemotherapy
cancer
G-CSF
febrile
Online Access:https://www.mdpi.com/1648-9144/57/7/675

Internet

https://www.mdpi.com/1648-9144/57/7/675

Similar Items